Alembic Pharmaceuticals Ltd

alembic-india.com BSE: 533573 NSE : APLLTD
About

Alembic Pharmaceuticals is a vertically integrated pharmaceutical company committed to deliver high-quality healthcare access to patients across the world.(Source : 201903 Annual Report Page No: 2)

Website BSE NSE
  • Market Cap ₹ 18,960 Cr.
  • Current Price ₹ 965
  • High / Low ₹ 1,129 / 435
  • Stock P/E 15.5
  • Book Value ₹ 241
  • Dividend Yield 0.73 %
  • ROCE 27.3 %
  • ROE 32.2 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is virtually debt free.
  • Company has delivered good profit growth of 27.78% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 26.67%
  • Company has been maintaining a healthy dividend payout of 18.09%

Cons

  • Promoter holding has decreased by -3.20% over last quarter
  • Tax rate seems low

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020
755 838 811 1,095 905 849 897 1,135 1,052 1,049 1,258 1,400
594 631 640 746 700 696 672 774 731 752 835 944
Operating Profit 160 207 172 349 205 153 225 361 321 296 423 456
OPM % 21% 25% 21% 32% 23% 18% 25% 32% 31% 28% 34% 33%
Other Income 0 0 0 2 3 1 3 0 0 121 0 3
Interest 1 1 1 5 5 4 5 7 7 7 6 2
Depreciation 26 28 25 26 27 27 32 33 34 36 36 37
Profit before tax 134 179 145 320 177 122 191 322 280 374 382 420
Tax % 21% 19% 22% 22% 22% 12% 19% 17% 17% 16% 16% 17%
Net Profit 105 144 114 251 139 108 155 269 231 314 319 348
EPS in Rs 5.57 7.65 6.05 13.32 7.35 5.71 8.23 14.25 12.26 16.67 16.90 17.72
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 TTM
1,165 1,374 1,493 1,844 2,019 3,009 2,986 2,945 3,660 4,133 4,759
1,009 1,166 1,249 1,485 1,611 2,026 2,353 2,313 2,782 2,931 3,262
Operating Profit 156 209 244 359 408 983 633 633 879 1,201 1,497
OPM % 13% 15% 16% 19% 20% 33% 21% 21% 24% 29% 31%
Other Income 4 13 13 4 3 7 3 7 6 126 124
Interest 28 38 24 10 3 4 3 2 15 25 22
Depreciation 30 34 35 40 44 72 83 102 106 136 143
Profit before tax 102 150 198 312 363 914 550 535 765 1,167 1,456
Tax % 20% 20% 21% 24% 21% 24% 22% 21% 20% 17%
Net Profit 82 121 157 238 287 699 431 422 611 969 1,212
EPS in Rs 6.39 8.35 12.64 15.20 37.06 22.84 22.38 32.42 51.42 63.55
Dividend Payout % 7% 22% 30% 24% 23% 11% 18% 18% 17% 19%
Compounded Sales Growth
10 Years:%
5 Years:15%
3 Years:11%
TTM:26%
Compounded Profit Growth
10 Years:%
5 Years:28%
3 Years:31%
TTM:82%
Stock Price CAGR
10 Years:%
5 Years:7%
3 Years:24%
1 Year:69%
Return on Equity
10 Years:%
5 Years:30%
3 Years:27%
Last Year:32%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions
Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Sep 2020
38 38 38 38 38 38 38 38 38 38 39
Reserves 239 323 422 592 796 1,493 1,830 2,157 2,675 3,308 4,701
Borrowings 328 353 187 109 194 0 8 622 1,059 1,687 600
238 277 352 423 484 651 634 862 777 846 1,096
Total Liabilities 816 991 999 1,162 1,511 2,182 2,509 3,678 4,549 5,879 6,437
272 268 344 397 489 697 799 918 1,085 1,276 1,260
CWIP 26 58 32 21 83 92 348 741 1,107 1,570 1,825
Investments 3 3 3 33 33 37 103 299 506 833 898
514 661 619 711 906 1,355 1,259 1,720 1,850 2,199 2,454
Total Assets 816 991 999 1,162 1,511 2,182 2,509 3,678 4,549 5,879 6,437

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
105 125 274 263 180 848 327 305 809 540
-57 -56 -67 -111 -199 -292 -511 -794 -754 -822
-47 -45 -229 -151 18 -276 -96 498 80 166
Net Cash Flow 1 24 -21 1 -1 280 -280 9 135 -116

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
ROCE % 28% 33% 47% 41% 72% 32% 23% 24% 27%
Debtor Days 63 50 57 52 61 45 57 77 54 69
Inventory Turnover 2.77 2.60 2.58 2.19 1.90 1.72 1.55 1.39 1.16

Shareholding Pattern

Numbers in percentages

Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020
72.68 72.93 72.96 72.96 72.96 72.97 72.97 72.97 72.97 72.97 72.97 69.77
10.46 9.16 8.73 9.32 9.37 9.50 9.56 9.55 9.23 8.29 7.30 7.03
3.88 5.16 5.57 5.56 5.68 5.48 5.41 6.42 6.73 6.86 7.10 9.43
12.98 12.75 12.74 12.16 11.99 12.05 12.06 11.06 11.07 11.88 12.63 13.76

Documents

Recent announcements


View all

Annual reports

Credit ratings